SCHEMBL22062767

SCHEMBL22062767

c1ccc2c(-c3c4ccccc4c(-c4cccc5cc(-c6cccc7oc8ccccc8c67)ccc45)c4ccccc34)cccc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ L3MBTL1 Q9Y468 2/20 0.41
▸ TDP1 Q9NUW8 1/20 0.41
▸ ALOX5 P09917 1/20 0.40
▸ HCRTR1 O43613 1/20 0.39
▸ PSD A5PKW4 1/20 0.38
▸ ALDH1A1 P00352 3/20 0.37
▸ HSD17B10 Q99714 3/20 0.37
▸ KDM4E B2RXH2 2/20 0.37
▸ CYP1A2 P05177 1/20 0.37
▸ CYP2C19 P33261 1/20 0.37
▸ RAB9A P51151 1/20 0.37
▸ ATM Q13315 1/20 0.37
▸ HPGD P15428 2/20 0.37
▸ MCL1 Q07820 1/20 0.37
▸ ACMSD Q8TDX5 1/20 0.37
▸ GAA P10253 1/20 0.37
▸ MAPT P10636 1/20 0.37
▸ SOS1 Q07889 1/20 0.36
▸ CASP3 P42574 1/20 0.36
▸ SENP7 Q9BQF6 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22952940 0.94 TDP1 (0.41) L3MBTL1TDP1ALOX5HCRTR1PSD
SCHEMBL26950236 0.94 L3MBTL1 (0.41) L3MBTL1TDP1ALOX5HCRTR1PSD
SCHEMBL22062768 0.93 ALOX5 (0.37) L3MBTL1TDP1ALOX5HCRTR1ALDH1A1
SCHEMBL24178060 0.92 ALOX5 (0.36) L3MBTL1TDP1ALOX5HCRTR1ALDH1A1
SCHEMBL22062769 0.92 GPR84 (0.40) L3MBTL1TDP1ALOX5HCRTR1ALDH1A1
SCHEMBL22063384 0.92 TDP1 (0.39) L3MBTL1TDP1ALOX5HCRTR1ALDH1A1
SCHEMBL22088900 0.91 L3MBTL1 (0.38) L3MBTL1TDP1ALOX5PSDALDH1A1
SCHEMBL26950368 0.90 CA12 (0.37) L3MBTL1TDP1ALOX5HCRTR1PSD
SCHEMBL22936534 0.89 TDP1 (0.38) L3MBTL1TDP1ALOX5PSDALDH1A1
SCHEMBL23955082 0.89 TDP1 (0.38) L3MBTL1TDP1ALOX5PSDALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20200185620-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE IDEMITSU KOSAN CO., LTD. (JP) 2020-06-11 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200185620-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT ELEMENT, AND ELECTRONIC DEVICE EMC2, NFE2L2, AOC2 L3MBTL1 3064/4885TDP1 4482/4885ALOX5 2455/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback